A cohort study of intrapartum group B streptococcus prophylaxis on atopic dermatitis in 2-year-old children

BMC Pediatrics

Research

Ren Jing¹  Ding Xin¹  Zhang Chunmei²  Zhang Hong²  Li Hui²  Wang Yang²  Yin Xiaoping²  Xu Kang²  Zhou Baojian² 

[1] Children’s Hospital of Soochow University, Soochow, Jiangsu, China;Taixing People’s Hospital, Taizhou, Jiangsu, China;

关键词: Group B streptococcus;    Intrapartum antibiotic prophylaxis;    Atopic dermatitis;   

DOI  :  10.1186/s12887-022-03758-5

 received in 2022-07-18, accepted in 2022-11-18,  发布年份 2022

来源: Springer

【 摘 要 】

ObjectiveTo understand the occurrence of atopic dermatitis (AD) in children aged 2 years on exposure to maternal group B streptococcus (GBS) antibiotic prophylaxis (IAP).DesignRetrospective cohort study of 2909 mother–child pairs.SettingTaixing People’s Hospital in Eastern China.ParticipantsTerm infants born 2018–2019, followed longitudinally from birth to 2 years.ExposuresThe GBS-IAP was defined as therapy with intravenous penicillin G or ampicillin or cefazolin ≥ 4 h prior to delivery to the mother. Reference infants were defined as born without or with other intrapartum antibiotic exposure.OutcomesThe logistic regression models were employed to analyze the effect of intrapartum GBS prophylaxis on AD in 2-year-old children during delivery. Analysis was a priori stratified according to the mode of delivery and adjusted for relevant covariates.ResultsThe cohorts showed that preventive GBS-IAP was potentially associated with increased incidence of AD in children delivered vaginally according to logistic regression models before and after covariate-adjusted treatment (OR: 6.719,95% CI: 4.730–9.544,P < 0.001;aOR: 6.562,95% CI: 4.302–10.008, P < 0.001).ConclusionProphylactic treatment of intrapartum GBS may raise the risk of AD in vaginally delivered children. These findings highlight the need to better understand the risk between childhood AD and current GBS-IAP intervention strategies.

【 授权许可】

CC BY   
© The Author(s) 2022

【 图 表 】

12888_2022_4392_Article_IEq3.gif

12982_2022_119_Article_IEq188.gif

Fig. 2